Patient-derived stem cells could improve drug research for Parkinson’s – medicalxpress.com

Next, the researchers attempted to rescue the toxin-exposed cells with various drug treatments that have shown promise in animal models of Parkinson’s, including the antioxidant coenzyme Q10 and the immunosuppressant rapamycin. All patient …